发明人黄志刚,韩伟,罗永刚. "Method for the Synthesis of 1-(4-Pyridinylmethyl)piperidine-4-carboxylic acid
1-(4-pyridinylmethyl)-4-piperidinecarboxylic acid
1-(pyridin-4-ylmethyl)piperidine-4-carboxylic acid
1-pyridin-4-ylmethyl-piperidine-4-carboxylic acid
1-pyridin-4-ylmethylpiperidine-4-carboxylic acid
6-Cyanonicotinic acid
6-Cyanopyridine-3-carboxylic acid
70165-31-0" [P]. 中国发明专利, 专利号 CN 108068052 B, 授权公告日 2018-12-24.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 6-氰基吡啶-3-甲酸 in Pharmaceutical Formulations". Molecules, 2016, 166, 1831-1838.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 6-氰基吡啶-3-甲酸 as an Impurity". Chemosphere, 2025, 759, 6243-6257.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-Pyridinylmethyl)piperidine-4-carboxylic acid
1-(4-pyridinylmethyl)-4-piperidinecarboxylic acid
1-(pyridin-4-ylmethyl)piperidine-4-carboxylic acid
1-pyridin-4-ylmethyl-piperidine-4-carboxylic acid
1-pyridin-4-ylmethylpiperidine-4-carboxylic acid
6-Cyanonicotinic acid
6-Cyanopyridine-3-carboxylic acid
70165-31-0 Using HRMS and NMR". Anal. Chim. Acta, 2022, 882, 4856-4863.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 6-氰基吡啶-3-甲酸 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 2213, (8), 4266-4291.